AGIO stock news
This page provides real-time market news, earnings updates, and company announcements related to Agios Pharmaceuticals, Inc. (AGIO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 16:10 EST
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-12 11:33:45
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss
Finviz2026-02-13 16:36:38
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Finviz2026-03-31 11:03:09
Agios Pharmaceuticals (NASDAQ: AGIO) announced that, following a successful pre-SNDA meeting with the U.S. Food and Drug Administration (FDA), the company is actively advancing the accelerated approval process for its candidate drug mitapivat for the treatment of sickle cell disease (SCD).
老虎证券2026-03-31 11:16:59
AGIO stock chart
AGIO stock detailsAGIO stock price change
On the last trading day, AGIO stock closed at 33.15 USD, with a price change of 0.70% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more